Clinical trial

A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®

NCT06037590

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-09-25

PhasePHASE1

Study timeline

Study start (actual)2023-09-25Date precision: day

Registry last updated2025-05-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinsonunresolved

Parkinson Diseaseunresolved

Parkinson's Disease and Parkinsonismunresolved

Interventions

Levodopa Cyclops®COMBINATION_PRODUCT

INBRIJA®COMBINATION_PRODUCT

Sponsors & collaborators

PureIMS B.V.lead sponsor

Cooperative Clinical Drug Research and Development AG (CCDRD AG)collaborator

Mapped research locations

SofiaBulgaria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06037590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.